|
|
Volumn 130, Issue 7, 2000, Pages 701-704
|
|
The use of 1H-NMR spectroscopy for predicting the efficiency of neoadjuvant chemotherapy of breast cancer
a a a a a a a |
|
Author keywords
1H NMR; Breast cancer; Degree of therapeutic pathomorphosis; Low molecular weight metabolites; Neoadjuvant chemotherapy
|
|
Indexed keywords
AMINO ACID;
ANTINEOPLASTIC AGENT;
CHOLINE DERIVATIVE;
CISPLATIN;
CREATININE;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
EPIRUBICIN;
FLUOROURACIL;
LACTIC ACID;
METHOTREXATE;
PROTON;
ADULT;
AGED;
ARTICLE;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER TISSUE;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DISEASE COURSE;
DRUG EFFICACY;
DRUG SENSITIVITY;
FEMALE;
HUMAN;
HUMAN TISSUE;
METABOLITE;
PREDICTION;
PROTON NUCLEAR MAGNETIC RESONANCE;
REGRESSION ANALYSIS;
TISSUE LEVEL;
TREATMENT OUTCOME;
ADJUVANT CHEMOTHERAPY;
BREAST TUMOR;
METABOLISM;
MIDDLE AGED;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
PATHOLOGY;
PREDICTION AND FORECASTING;
ADULT;
AGED;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
FEMALE;
HUMANS;
MAGNETIC RESONANCE SPECTROSCOPY;
MIDDLE AGED;
PREDICTIVE VALUE OF TESTS;
PROTONS;
|
|
EID: 0034353171
PISSN: 00074888
EISSN: None
Source Type: Journal
DOI: 10.1007/bf02682110 Document Type: Article |
|
Times cited : (4)
|
|
References (5)
|
